Dr. Toney’s career has spanned both the pharmaceutical industry and academia. His academic training is in Chemistry (B.S., University of Virginia; M.S. and Ph.D., Northwestern University) and included research experience as a postdoctoral fellow in Molecular Biology (Dana Farber Cancer Institute, Harvard Medical School) and in Chemical Biology (Massachusetts Institute of Technology).
After Robert Sell earned his B.S. in Chemisty with High Distinctions from UVA in 1975, he worked for four years in the U.S. Navy as an instructor at the Naval Nuclear Power School teaching Chemistry, Radiological Fundamentals, and Materials Science. From 1979 to 2009, he worked with Corning Incorporated in a wide variety of positions in manufacturing, process engineering, product and market development, strategy development, intellectual property, product line management.
Professor Santos earned his B.S. degree from the University of Virginia and continued at UVA for his Ph.D. studies with Timothy Macdonald. After graduating in 2002, he was an NIH Postdoctoral Fellow at Harvard University in the Department of Chemistry and Chemical Biology with Professor Gregory L. Verdine. He is now an assistant professor at Virginia Tech.
Director of Chemical Biology at and Founding Member of the Broad Institute of Harvard and MIT, where he is a Investigator. He is also the Morris Loeb Professor of Chemistry and Chemical Biology at Harvard University. He is a member of the National Academy of Sciences and the American Academy of Arts & Sciences (1995).
Dr. Rohlfing is the division director of the Chemical Sciences, Geosciences and Biosciences Division in the Office of Basic Energy Sciences (BES), Office of Science, U.S. Department of Energy. He joined BES in 1997 and served as program manager for the Atomic, Molecular and Optical Sciences program from 2000 to 2003 and as team leader for Fundamental Interactions from 2003 until October 2006, when he became division director. Dr. Rohlfing received his B.S. in Chemistry from the University of Virginia in 1977 and his Ph.D. in Physical Chemistry from Princeton University in 1982.
Professor Rojas earned his B.A. from the University of Virginia in 1989, where he did research with Ralph O. Allen on neutron activation analysis of archaeological artifacts. He received a Ph.D. in organic chemistry from Indiana University, working with David R. Williams. Following a postdoc with Julius Rebek at both MIT and The Scripps Research Institute, Professor Rojas joined the faculty at Barnard College, a liberal arts college for women in New York City.
Brian Pollok, Ph.D., is Life Technologies’ Chief Scientific Officer and Head of Global Science & Innovation based in Carlsbad, CA. He oversees the allocation of more than $350M in R&D funds annually, which has yielded innovative new products in the areas of DNA sequencing, cell analysis, and molecular biology. Dr. Pollok has been with Life Tech since 2003, previously serving as CSO and Head of Global R&D for Invitrogen, and as VP of R&D for the company’s Discovery Sciences unit in Madison, WI.
Professor Love is an assistant professor in chemical engineering at MIT. He is also an associate member at the Eli and Edythe L. Broad Institute, and associate faculty at the Ragon Institute of MGH, MIT, and Harvard. He was named a Dana Scholar for Human Immunology and a Keck Distinguished Young Scholar in Medical Research in 2009.
After graduating from UVa with a B.S in Chemistry, Christopher Ferenc received his law degree from Seton Hall University School of Law, in Newark, NJ. His background in chemistry motivated him to pursue a career in the field of intellectual property law. His professional experience in this field includes interning with a U.S. Magistrate Judge and serving as legal support staff for a U.S. Congressional Committee. Currently, he is employed as a Patent Attorney in Washington, D.C.
Professor Dowd earned her B.A. degree from the University of Virginia and her Ph.D. in Medicinal Chemistry from Virginia Commonwealth University (working with Richard Glennon). Following postdoctoral work at the University of Pennsylvania (with Irwin Chaiken), she joined the NIH where she directed a synthetic chemistry group finding novel small molecules against Mycobacterium tuberculosis.